摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 4-hydroxy-2-(hydroxymethyl)butanoate | 1459806-66-6

中文名称
——
中文别名
——
英文名称
ethyl 4-hydroxy-2-(hydroxymethyl)butanoate
英文别名
——
ethyl 4-hydroxy-2-(hydroxymethyl)butanoate化学式
CAS
1459806-66-6
化学式
C7H14O4
mdl
——
分子量
162.186
InChiKey
GRNJETWQMVMBQY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    11
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    66.8
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-氧代四氢呋喃-3-羧酸乙酯 在 samarium diiodide 、 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以83%的产率得到ethyl 4-hydroxy-2-(hydroxymethyl)butanoate
    参考文献:
    名称:
    底物导向的电子转移反应。使用 SmI2–H2O 化学选择性还原环酯的显着速率提高:机制、范围和合成效用
    摘要:
    底物导向反应在有机合成中起着关键作用,但在通过自由基机制进行的反应中并不常见。在此,我们提供了实验证据,表明 Sm(II) 介导的环酯还原速率显着加速,这是通过导向基团和镧系元素中心之间的瞬时螯合实现的。该过程在使用 SmI2-H2O 还原环酯时具有前所未有的化学选择性,并且首次在广泛的底物范围内进行。还公开了对形成碳-碳键的选择性起源和合成应用的初步研究。
    DOI:
    10.1021/ja4078864
点击查看最新优质反应信息

文献信息

  • 2-Iminopyrrolidine derivatives
    申请人:Suzuki Shuichi
    公开号:US20050245592A1
    公开(公告)日:2005-11-03
    A 2-iminopyrrolidine derivative represented by the formula: wherein ring B represents a benzene ring, pyridine ring, etc.; R 101 -R 103 represent hydrogen, halogen, C 1-6 alkyl, etc.; R 5 represents hydrogen, C 1-6 alkyl, C 1-6 alkoxy-C 1-6 alkyl, etc.; R 6 represents hydrogen, C 1-6 alkyl, C 1-6 alkyloxycarbonyl, etc.; Y 1 represents a single bond, —CH 2 —, etc.; Y 2 represents a single bond, —CO—, etc.; and Ar represents hydrogen, a group represented by the formula: [wherein R 10 -R 14 represent hydrogen, C 1-6 alkyl, hydroxyl, C 1-6 alkoxy, etc.; and R 11 and R 12 or R 12 and R 13 may bond together to form a 5- to 8-membered heterocyclic ring], etc.}, or a salt thereof.
    一种2-伊米诺吡咯烷衍生物,其化学式为:其中环B代表苯环、吡啶环等;R101-R103代表氢、卤素、C1-6烷基等;R5代表氢、C1-6烷基、C1-6烷氧基-C1-6烷基等;R6代表氢、C1-6烷基、C1-6烷氧羰基等;Y1代表单键,-CH2-等;Y2代表单键,-CO-等;Ar代表氢,一个由以下式子表示的基团:[其中R10-R14代表氢、C1-6烷基、羟基、C1-6烷氧基等;R11和R12或R12和R13可以结合形成5-至8-成员的杂环],等,或其盐。
  • Piperazine compounds and medicinal use thereof
    申请人:Mitsubishi Pharma Corporation
    公开号:US20030018034A1
    公开(公告)日:2003-01-23
    The present invention relates to a piperazine compound of the formula 1 wherein R 1 and R 2 are each hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, nitro, hydroxy or cyano, R 3 , R 4 and R 5 are each hydrogen, halogen, lower alkyl, lower alkoxy, nitro, amino, substituted amino or hydroxy, R 6 and R 7 are each hydrogen, lower alkyl, lower alkyl substituted by halogen, aralkyl, acyl or lower acyl substituted by halogen, R 8 and R 9 are each hydrogen or lower alkyl, Y is lower alkylene and the like, and ring A is phenyl, pyrimidyl, thiazolyl, pyridyl, pyrazyl or imidazolyl, a pharmaceutically acceptable salt thereof and pharmaceutical agents containing these compounds. The compound of the present invention has superior TNF-&agr; production inhibitory effect and/or IL-10 production promoting effect, and, since it is free of or shows only strikingly reduced expression of an effect on the central nervous system, the compound is useful as a highly safe and superior TNF-&agr; production inhibitor an/or IL-10 production promoter and is useful as an agent for the prophylaxis or treatment of various diseases caused by abnormal TNF-&agr; production, diseases curable with IL-10, such as chronic inflammatory diseases, acute inflammatory diseases, inflammatory diseases due to infection, autoimmune diseases, allergic diseases, and TNF-&agr; mediated diseases.
    本发明涉及一种哌嗪化合物,其化学式为1,其中R1和R2分别为氢、卤素、低碳基、低氧基、氨基、取代氨基、硝基、羟基或氰基,R3、R4和R5分别为氢、卤素、低碳基、低氧基、硝基、氨基、取代氨基或羟基,R6和R7分别为氢、低碳基、被卤素取代的低碳基、芳基烷基、酰基或被卤素取代的低酰基,R8和R9分别为氢或低碳基,Y为低碳基亚烷基等,环A为苯基、嘧啶基、噻唑基、吡啶基、吡唑基或咪唑基,以及其药学上可接受的盐和含有这些化合物的药物制剂。本发明的化合物具有优异的TNF-α产生抑制作用和/或IL-10产生促进作用,并且由于其不具有或仅表现出对中枢神经系统的作用明显降低,因此该化合物可用作高度安全和优越的TNF-α产生抑制剂和/或IL-10产生促进剂,并可用作预防或治疗由异常TNF-α产生引起的各种疾病、可用IL-10治愈的疾病,例如慢性炎症性疾病、急性炎症性疾病、由感染引起的炎症性疾病、自身免疫性疾病、过敏性疾病和TNF-α介导的疾病。
  • Method for the production of radiation-curable urethane (meth) acrylates
    申请人:Heischkel Yvonne
    公开号:US20060052571A1
    公开(公告)日:2006-03-09
    A radiation-curable urethane(meth)acrylate, a process for preparing a radiation-curable urethane(meth)acrylate, and a coating composition comprising a radiation-curable urethane(meth)acrylate, in which the radiation-curable urethane(meth)acrylate is tough and resilient and useful in coating systems for a variety of substrates.
    一种辐射可固化的环氧基脲酸酯(甲基)丙烯酸酯,制备辐射可固化的环氧基脲酸酯的方法,以及包括辐射可固化的环氧基脲酸酯的涂层组成物,其中辐射可固化的环氧基脲酸酯坚韧、有弹性,并且可用于各种基材的涂覆系统。
  • Methods For Producing Isoindole Derivatives
    申请人:Yoshizawa Kazuhiro
    公开号:US20080214834A1
    公开(公告)日:2008-09-04
    The present invention relates to a method for producing an isoindole derivative (compound (II)) with the following general formula (II): (wherein R 1 and R 2 each independently represents a C 1-6 alkyl group) or a salt thereof, comprising the step of cyclizing, in a solvent, compound (I) with the following general formula (I): (wherein R 1 and R 2 have the same meanings as R 1 and R 2 in formula (II) above) or a salt thereof, or their hydrate or solvate in the presence of a base (Step 1).
    本发明涉及一种制备isoindole衍生物(化合物(II))或其盐的方法,该化合物具有以下一般式(II):(其中R1和R2各自独立地表示C1-6烷基基团),包括在溶剂中环化化合物(I)的步骤,该化合物具有以下一般式(I):(其中R1和R2具有与上述公式(II)中的R1和R2相同的含义),或它们的水合物或溶剂化物,在碱存在下(步骤1)。
  • Method for producing polyetherols
    申请人:Wartini Alexander
    公开号:US20050148802A1
    公开(公告)日:2005-07-07
    The invention provides a process for preparing polyetherols of polyhydric alcohols by reacting an alkylene oxide with the appropriate polyhydric alcohol in the presence of a base and in the presence or absence of a solvent, wherein the polyhydric alcohol used has a formaldehyde acetal content of less than 500 ppm.
    本发明提供了一种制备多元醇的聚醚醇的方法,通过在碱的存在下,在溶剂的存在或缺失下,将一种烷基氧化物与适当的多元醇反应,其中所使用的多元醇的甲醛缩醛含量小于500 ppm。
查看更多